Black Diamond Therapeutics Presents Real-World Treatment Practices and Patient Outcomes in Newly Diagnosed NSCLC Patients with Non-Classical Mutations at the European Society for Medical Oncology ( ESMO ) Congress 2024
Treatment data were analyzed from 3,276 cases of patients with newly diagnosed EGFR mutant NSCLC from Guardant Health ...
| Ticker |
Sentiment |
Impact |
|
BDTX
|
Neutral
|
46 %
|
|
GH
|
Neutral
|
9 %
|
